Thomas Sweeney Heard

Array ( [id] => 8290344 [patent_doc_number] => 20120178670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'ACYLATED GLUCAGON ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/383783 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18234 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6618139 [patent_doc_number] => 20100324060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING HCV' [patent_app_type] => utility [patent_app_number] => 12/818421 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5761 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324060.pdf [firstpage_image] =>[orig_patent_app_number] => 12818421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616596 [patent_doc_number] => 20100323989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'PHARMACEUTICAL COMBINATIONS USEFUL FOR TREATING HCV' [patent_app_type] => utility [patent_app_number] => 12/817392 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10190 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323989.pdf [firstpage_image] =>[orig_patent_app_number] => 12817392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11197261 [patent_doc_number] => 09427456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Peptide therapy for increasing platelet levels' [patent_app_type] => utility [patent_app_number] => 13/378061 [patent_app_country] => US [patent_app_date] => 2010-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 19025 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416623 [patent_doc_number] => 20120244122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'Peptides for the Treatment of HCV Infections' [patent_app_type] => utility [patent_app_number] => 13/321785 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22087 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427626 [patent_doc_number] => 08703700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Bimacrocylic HCV NS3 protease inhibitors' [patent_app_type] => utility [patent_app_number] => 13/322120 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22129 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6589398 [patent_doc_number] => 20100291623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'PROCESS FOR PRODUCING ALPHA-GLYCOSYLATED DIPEPTIDE AND METHOD OF ASSAYING ALPHA-GLYCOSYLATED DIPEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/786005 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8907 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291623.pdf [firstpage_image] =>[orig_patent_app_number] => 12786005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266472 [patent_doc_number] => 20100298231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'PMMA BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/778167 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13449 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298231.pdf [firstpage_image] =>[orig_patent_app_number] => 12778167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266516 [patent_doc_number] => 20100298240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'PMMA BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/778169 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13443 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298240.pdf [firstpage_image] =>[orig_patent_app_number] => 12778169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725100 [patent_doc_number] => 08404214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'PMMA binding peptides' [patent_app_type] => utility [patent_app_number] => 12/778180 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13417 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12778180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253071 [patent_doc_number] => 20120157395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'ANTI-INFLAMMATORY AGENT FOR ORAL APPLICATION, AND ANTI-INFLAMMATORY PEPTIDE FOR ORAL APPLICATION' [patent_app_type] => utility [patent_app_number] => 13/383673 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5563 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157395.pdf [firstpage_image] =>[orig_patent_app_number] => 13383673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483766 [patent_doc_number] => 20120283173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'NOVEL COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION' [patent_app_type] => utility [patent_app_number] => 13/319262 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7709 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290364 [patent_doc_number] => 20120178694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'Modified Compstatin With Peptide Backbone And C-Terminal Modifications' [patent_app_type] => utility [patent_app_number] => 13/318272 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13087 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339376 [patent_doc_number] => 20100247450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'USE OF ERYTHROPOIETIN' [patent_app_type] => utility [patent_app_number] => 12/759275 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12315 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247450.pdf [firstpage_image] =>[orig_patent_app_number] => 12759275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339382 [patent_doc_number] => 20100247451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'USE OF ERYTHROPOIETIN' [patent_app_type] => utility [patent_app_number] => 12/759299 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12310 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247451.pdf [firstpage_image] =>[orig_patent_app_number] => 12759299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339384 [patent_doc_number] => 20100247452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'USE OF ERYTHROPOIETIN' [patent_app_type] => utility [patent_app_number] => 12/759321 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12311 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247452.pdf [firstpage_image] =>[orig_patent_app_number] => 12759321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351171 [patent_doc_number] => 20100331247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'PEPTIDE THERAPY FOR HYPERGLYCEMIA' [patent_app_type] => utility [patent_app_number] => 12/755907 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15023 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331247.pdf [firstpage_image] =>[orig_patent_app_number] => 12755907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063681 [patent_doc_number] => 20110245182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Topical Uses of Szeto-Schiller Peptides' [patent_app_type] => utility [patent_app_number] => 12/755079 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4830 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245182.pdf [firstpage_image] =>[orig_patent_app_number] => 12755079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993478 [patent_doc_number] => 20110015131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'METHODS FOR PREVENTING AND TREATING ALZHEIMER\'S DISEASE (AD)' [patent_app_type] => utility [patent_app_number] => 12/752451 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6343 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015131.pdf [firstpage_image] =>[orig_patent_app_number] => 12752451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756666 [patent_doc_number] => 20120028887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'LIPOPEPTIDE INHIBITORS OF HIV-1' [patent_app_type] => utility [patent_app_number] => 13/260902 [patent_app_country] => US [patent_app_date] => 2010-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15210 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028887.pdf [firstpage_image] =>[orig_patent_app_number] => 13260902 [rel_patent_id] =>[rel_patent_doc_number] =>)